{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:07:28Z","timestamp":1770840448368,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T00:00:00Z","timestamp":1415232000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00592-014-0681-0","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T22:10:14Z","timestamp":1416003014000},"page":"461-471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Xenin-25[Lys13PAL]: a novel long-acting acylated analogue of xenin-25 with promising antidiabetic potential"],"prefix":"10.1007","volume":"52","author":[{"given":"V. A.","family":"Gault","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M. A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. R.","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Parthsarathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,6]]},"reference":[{"key":"681_CR1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0167-0115(02)00281-1","volume":"111","author":"GE Feurle","year":"2003","unstructured":"Feurle GE, Ikonomu S, Partoulas G, Stoschus B, Hamscher G (2003) Xenin plasma concentrations during modified sham feeding and during meals of different composition demonstrated by radioimmunoassay and chromatography. Regul Pept 111:153\u2013159","journal-title":"Regul Pept"},{"key":"681_CR2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/oby.2008.652","volume":"17","author":"JH Cooke","year":"2009","unstructured":"Cooke JH, Patterson M, Patel SR, Smith KL, Ghatei MA, Bloom SR, Murphy KG (2009) Peripheral and central administration of xenin and neurotensin suppress food intake in rodents. Obesity (Silver Spring) 17:1135\u20131143","journal-title":"Obesity (Silver Spring)"},{"key":"681_CR3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1677\/JOE-10-0085","volume":"207","author":"AI Taylor","year":"2010","unstructured":"Taylor AI, Irwin N, McKillop AM, Patterson S, Flatt PR, Gault VA (2010) Evaluation of the degradation and metabolic effects of the gut peptide xenin on insulin secretion, glycaemic control and satiety. J Endocrinol 207:87\u201393","journal-title":"J Endocrinol"},{"key":"681_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2982.2006.00881.x","volume":"19","author":"Y Kamiyama","year":"2007","unstructured":"Kamiyama Y, Aihara R, Nakabayashi T, Mochiki E, Asao T, Kuwano H (2007) The peptide hormone xenin induces gallbladder contractions in conscious dogs. Neurogastroenterol Motil 19:33\u2013240","journal-title":"Neurogastroenterol Motil"},{"key":"681_CR5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2337\/db08-0260","volume":"58","author":"A Leckstrom","year":"2009","unstructured":"Leckstrom A, Kim ER, Wong D, Mizuno TM (2009) Xenin, a gastrointestinal peptide, regulates feeding independent of the melanocortin signaling pathway. Diabetes 58:87\u201394","journal-title":"Diabetes"},{"key":"681_CR6","doi-asserted-by":"crossref","first-page":"19842","DOI":"10.1074\/jbc.M110.129304","volume":"2285","author":"BM Wice","year":"2010","unstructured":"Wice BM, Wang S, Crimmins DL, Diggs-Andrews KA, Althage MC, Ford EL, Tran H, Ohlendorf M, Griest TA, Wang Q, Fisher SJ, Ladenson JH, Polonsky KS (2010) Xenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism. J Biol Chem 2285:19842\u201319853","journal-title":"J Biol Chem"},{"key":"681_CR7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bcp.2012.04.015","volume":"84","author":"CM Martin","year":"2012","unstructured":"Martin CM, Gault VA, McClean S, Flatt PR, Irwin N (2012) Degradation, insulin secretion, glucose-lowering and GIP additive actions of a palmitate-derivatised analogue of xenin-25. Biochem Pharmacol 84:312\u2013319","journal-title":"Biochem Pharmacol"},{"key":"681_CR8","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.2337\/dc11-s227","volume":"34","author":"JJ Holst","year":"2011","unstructured":"Holst JJ, Knop FK, Vilsb\u00f8ll T, Krarup T, Madsbad S (2011) Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes. Diabetes Care 34:S251\u2013S257","journal-title":"Diabetes Care"},{"key":"681_CR9","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1210\/endo-99-3-780","volume":"99","author":"RA Pederson","year":"1976","unstructured":"Pederson RA, Brown JC (1976) The insulinotropic action of gastric inhibitory polypeptide in the perfused isolated rat pancreas. Endocrinology 99:780\u2013785","journal-title":"Endocrinology"},{"key":"681_CR10","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2165\/11592810-000000000-00000","volume":"71","author":"B Gallwitz","year":"2011","unstructured":"Gallwitz B (2011) Glucagon-like peptide-1 analogues for Type 2 diabetes mellitus: current and emerging agents. Drugs 71:1675\u20131688","journal-title":"Drugs"},{"key":"681_CR11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/JOE-13-0617","volume":"221","author":"CM Martin","year":"2014","unstructured":"Martin CM, Parthsarathy V, Pathak V, Gault VA, Flatt PR, Irwin N (2014) Characterisation of the biological activity of xenin-25 degradation fragment peptides. J Endocrinol 221:193\u2013200","journal-title":"J Endocrinol"},{"key":"681_CR12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bone.2013.07.003","volume":"56","author":"A Mieczkowska","year":"2013","unstructured":"Mieczkowska A, Irwin N, Flatt PR, Chappard D, Mabilleau G (2013) Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality. Bone 56:337\u2013342","journal-title":"Bone"},{"key":"681_CR13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00252768","volume":"20","author":"PR Flatt","year":"1981","unstructured":"Flatt PR, Bailey CJ (1981) Abnormal plasma glucose and insulin responses in heterozygous lean (ob\/+) mice. Diabetologia 20:573\u2013577","journal-title":"Diabetologia"},{"key":"681_CR14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.beem.2009.03.001","volume":"23","author":"N Irwin","year":"2009","unstructured":"Irwin N, Flatt PR (2009) Therapeutic potential for GIP receptor agonists and antagonists. Best Pract Res Clin Endocrinol Metab 23:499\u2013512","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"681_CR15","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1463-1326.2010.01259.x","volume":"12","author":"DW Porter","year":"2010","unstructured":"Porter DW, Kerr BD, Flatt PR, Holscher C, Gault VA (2010) Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance. Diabetes Obes Metab 12:891\u2013899","journal-title":"Diabetes Obes Metab"},{"key":"681_CR16","first-page":"265","volume":"208","author":"VA Gault","year":"2011","unstructured":"Gault VA, Porter DW, Irwin N, Flatt PR (2011) Comparison of sub-chronic metabolic effects of stable forms of naturally occurring GIP(1-30) and GIP(1-42) in high-fat fed mice. J Endocrinol 208:265\u2013271","journal-title":"J Endocrinol"},{"key":"681_CR17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bcp.2006.06.013","volume":"72","author":"N Irwin","year":"2006","unstructured":"Irwin N, Clarke GC, Green BD, Greer B, Harriott P, Gault VA, O\u2019Harte FP, Flatt PR (2006) Evaluation of the antidiabetic activity of DPP IV resistant N-terminally modified versus mid-chain acylated analogues of glucose-dependent insulinotropic polypeptide. Biochem Pharmacol 72:719\u2013728","journal-title":"Biochem Pharmacol"},{"key":"681_CR18","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2337\/db11-1451","volume":"61","author":"BM Wice","year":"2012","unstructured":"Wice BM, Reeds DN, Tran HD, Crimmins DL, Patterson BW, Dunai J, Wallendorf MJ, Ladenson JH, Villareal DT, Polonsky KS (2012) Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes. Diabetes 61:1793\u20131800","journal-title":"Diabetes"},{"key":"681_CR19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/dom.12227","volume":"16","author":"V Pathak","year":"2014","unstructured":"Pathak V, Vasu S, Flatt PR, Irwin N (2014) Effects of chronic exposure of clonal \u03b2-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1. Diabetes Obes Metab 16:357\u2013365","journal-title":"Diabetes Obes Metab"},{"key":"681_CR20","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbrc.2007.08.115","volume":"362","author":"S Piteau","year":"2007","unstructured":"Piteau S, Olver A, Kim SJ, Winter K, Pospisilik JA, Lynn F, Manhart S, Demuth HU, Speck M, Pederson RA, McIntosh CH (2007) Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat. Biochem Biophys Res Commun 362:1007\u20131012","journal-title":"Biochem Biophys Res Commun"},{"key":"681_CR21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/jcem-55-2-329","volume":"55","author":"M Salera","year":"1982","unstructured":"Salera M, Giacomoni P, Pironi L, Cornia G, Capelli M, Marini A, Benfenati F, Miglioli M, Barbara L (1982) Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity. J Clin Endocrinol Metab 55:329\u2013336","journal-title":"J Clin Endocrinol Metab"},{"key":"681_CR22","unstructured":"Marks V (1988) In: James WPT, Parker SW (eds) Current approaches: obesity. Southampton, Duphar Medical Relations, pp 13\u201319"},{"key":"681_CR23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0024-3205(99)00314-8","volume":"66","author":"RG Yip","year":"2000","unstructured":"Yip RG, Wolfe MM (2000) GIP biology and fat metabolism. Life Sci 66:91\u2013103","journal-title":"Life Sci"},{"key":"681_CR24","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/BF01117003","volume":"5","author":"P Kwasowski","year":"1985","unstructured":"Kwasowski P, Flatt PR, Bailey CJ, Marks V (1985) Effects of fatty acid chain length and saturation on gastric inhibitory polypeptide release in obese hyperglycaemic (ob\/ob) mice. Biosci Rep 5:701\u2013705","journal-title":"Biosci Rep"},{"key":"681_CR25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0167-0115(03)00147-2","volume":"115","author":"RA Silvestre","year":"2003","unstructured":"Silvestre RA, Rodr\u00edguez-Gallardo J, Egido EM, Hern\u00e1ndez R, Marco J (2003) Stimulatory effect of xenin-8 on insulin and glucagon secretion in the perfused rat pancreas. Regul Pept 115:25\u201329","journal-title":"Regul Pept"},{"key":"681_CR26","doi-asserted-by":"crossref","first-page":"G301","DOI":"10.1152\/ajpgi.00383.2013","volume":"306","author":"S Chowdhury","year":"2014","unstructured":"Chowdhury S, Reeds DN, Crimmins DL, Patterson BW, Laciny E, Wang S, Tran HD, Griest TA, Rometo DA, Dunai J, Wallendorf MJ, Ladenson JH, Polonsky K, Wice BM (2014) Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without type 2 diabetes. Am J Physiol Gastrointest Liver Physiol 306:G301\u2013G309","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"681_CR27","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nm727","volume":"8","author":"K Miyawaki","year":"2002","unstructured":"Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, Hiai H, Mizunoya W, Fushiki T, Holst JJ, Makino M, Tashita A, Kobara Y, Tsubamoto Y, Jinnouchi T, Jomori T, Seino Y (2002) Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8:738\u2013742","journal-title":"Nat Med"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-014-0681-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-014-0681-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-014-0681-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T11:31:42Z","timestamp":1650627102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-014-0681-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["681"],"URL":"https:\/\/doi.org\/10.1007\/s00592-014-0681-0","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,6]]}}}